BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19798471)

  • 1. Extensive conservation of genomic imbalances in canine transmissible venereal tumors (CTVT) detected by microarray-based CGH analysis.
    Thomas R; Rebbeck C; Leroi AM; Burt A; Breen M
    Chromosome Res; 2009; 17(7):927-34. PubMed ID: 19798471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of mitochondrial DNA transfer in canine transmissible venereal tumours obtained from dogs in Mexico.
    Bautista-Gómez L; Martínez-Castañeda S
    Mitochondrial DNA A DNA Mapp Seq Anal; 2017 Sep; 28(5):645-649. PubMed ID: 27159723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TP53 Polymorphisms allow for genetic sub-grouping of the canine transmissible venereal tumor.
    Sánchez-Servín A; Martínez S; Córdova-Alarcon E; Fajardo R
    J Vet Sci; 2009 Dec; 10(4):353-5. PubMed ID: 19934603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The T963C mutation of TP53 gene does not participate in the clonal origin of canine TVT.
    Vázquez-Mota N; Simón-Martínez J; Córdova-Alarcon E; Lagunes L; Fajardo R
    Vet Res Commun; 2008 Feb; 32(2):187-91. PubMed ID: 17668284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a genetic assay for canine transmissible venereal tumour diagnosis in Brazil.
    Castro KF; Strakova A; Tinucci-Costa M; Murchison EP
    Vet Comp Oncol; 2017 Jun; 15(2):615-618. PubMed ID: 27135875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of tumor infiltrating lymphocytes on the expression of MHC molecules in canine transmissible venereal tumor cells.
    Hsiao YW; Liao KW; Hung SW; Chu RM
    Vet Immunol Immunopathol; 2002 Aug; 87(1-2):19-27. PubMed ID: 12052339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canine transmissible venereal tumour: cytogenetic origin, immunophenotype, and immunobiology. A review.
    Mukaratirwa S; Gruys E
    Vet Q; 2003 Sep; 25(3):101-11. PubMed ID: 14535580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-mediated immunity and expression of MHC class I and class II molecules in dogs naturally infected by canine transmissible venereal tumor: Is there complete spontaneous regression outside the experimental CTVT?
    do Prado Duzanski A; Flórez LMM; Fêo HB; Romagnoli GG; Kaneno R; Rocha NS
    Res Vet Sci; 2022 Jul; 145():193-204. PubMed ID: 35240476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmissible [corrected] dog cancer genome reveals the origin and history of an ancient cell lineage.
    Murchison EP; Wedge DC; Alexandrov LB; Fu B; Martincorena I; Ning Z; Tubio JMC; Werner EI; Allen J; De Nardi AB; Donelan EM; Marino G; Fassati A; Campbell PJ; Yang F; Burt A; Weiss RA; Stratton MR
    Science; 2014 Jan; 343(6169):437-440. PubMed ID: 24458646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial genetic diversity, selection and recombination in a canine transmissible cancer.
    Strakova A; Ní Leathlobhair M; Wang GD; Yin TT; Airikkala-Otter I; Allen JL; Allum KM; Bansse-Issa L; Bisson JL; Castillo Domracheva A; de Castro KF; Corrigan AM; Cran HR; Crawford JT; Cutter SM; Delgadillo Keenan L; Donelan EM; Faramade IA; Flores Reynoso E; Fotopoulou E; Fruean SN; Gallardo-Arrieta F; Glebova O; Häfelin Manrique RF; Henriques JJ; Ignatenko N; Koenig D; Lanza-Perea M; Lobetti R; Lopez Quintana AM; Losfelt T; Marino G; Martincorena I; Martínez Castañeda S; Martínez-López MF; Meyer M; Nakanwagi B; De Nardi AB; Neunzig W; Nixon SJ; Onsare MM; Ortega-Pacheco A; Peleteiro MC; Pye RJ; Reece JF; Rojas Gutierrez J; Sadia H; Schmeling SK; Shamanova O; Ssuna RK; Steenland-Smit AE; Svitich A; Thoya Ngoka I; Vițălaru BA; de Vos AP; de Vos JP; Walkinton O; Wedge DC; Wehrle-Martinez AS; van der Wel MG; Widdowson SA; Murchison EP
    Elife; 2016 May; 5():. PubMed ID: 27185408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-based polymerase chain reaction for canine transmissible venereal tumor (CTVT) diagnosis.
    Setthawongsin C; Techangamsuwan S; Tangkawattana S; Rungsipipat A
    J Vet Med Sci; 2016 Aug; 78(7):1167-73. PubMed ID: 27075116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene-expression profiling to identify genes related to spontaneous tumor regression in a canine cancer model.
    Chiang HC; Liao AT; Jan TR; Wang YS; Lei HJ; Tsai MH; Chen MF; Lee CY; Lin YC; Chu RM; Lin CS
    Vet Immunol Immunopathol; 2013 Feb; 151(3-4):207-16. PubMed ID: 23237908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clonal origin and evolution of a transmissible cancer.
    Murgia C; Pritchard JK; Kim SY; Fassati A; Weiss RA
    Cell; 2006 Aug; 126(3):477-87. PubMed ID: 16901782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent advances in transmissible tumors].
    Yin TT; Wang L; Wang GD
    Yi Chuan; 2015 Nov; 37(11):1086-94. PubMed ID: 26582522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Origins and evolution of a transmissible cancer.
    Rebbeck CA; Thomas R; Breen M; Leroi AM; Burt A
    Evolution; 2009 Sep; 63(9):2340-9. PubMed ID: 19453727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of canine transmissible veneral tumor genotypes using the D-loop region of mitochondrial DNA.
    Bautista-Gómez LG; Martínez-Castañeda S; Córdova-Alarcón E; Vázquez-Chagoyán JC
    Genes Genet Syst; 2011; 86(5):351-5. PubMed ID: 22362033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computerized Cytomorphometric and Cytomorphological Analysis of Canine Transmissible Venereal Tumours.
    Setthawongsin C; Tangkawattana S; Rungsipipat A; Techangamsuwan S
    J Comp Pathol; 2018 Aug; 163():18-22. PubMed ID: 30213369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the multi-drug resistance 1, p53, b cell lymphoma 2, and bcl 2-associated X genes in the biologic behavior and chemotherapeutic resistance of canine transmissible venereal tumors.
    Alzate JM; Montoya-Florez LM; Pérez JE; Rocha NS; Pedraza-Ordonez FJ
    Vet Clin Pathol; 2019 Dec; 48(4):730-739. PubMed ID: 31777108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous canine immunotherapy: short-time generated dendritic cells loaded with canine transmissible venereal tumor-whole lysate.
    Franco-Molina MA; Ramos-Zayas Y; Coronado-Cerda EE; Mendoza-Gamboa E; Zapata-Benavides P; Santana-Krymskaya SE; Tamez-Guerra R; Rodríguez-Padilla C
    Immunopharmacol Immunotoxicol; 2018 Oct; 40(5):437-443. PubMed ID: 30507311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electroporation-mediated IL-12 gene therapy in a transplantable canine cancer model.
    Chuang TF; Lee SC; Liao KW; Hsiao YW; Lo CH; Chiang BL; Lin XZ; Tao MH; Chu RM
    Int J Cancer; 2009 Aug; 125(3):698-707. PubMed ID: 19431145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.